269 related articles for article (PubMed ID: 29858511)
1. Cytochrome P450 genotype-guided drug therapies: An update on current states.
Dong AN; Tan BH; Pan Y; Ong CE
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):991-1001. PubMed ID: 29858511
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics: the therapeutic drug monitoring of the future?
Ensom MH; Chang TK; Patel P
Clin Pharmacokinet; 2001; 40(11):783-802. PubMed ID: 11735602
[TBL] [Abstract][Full Text] [Related]
3. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.
Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J
Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342
[TBL] [Abstract][Full Text] [Related]
4. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in drug regulation: promise, potential and pitfalls.
Shah RR
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1617-38. PubMed ID: 16096112
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
Kirchheiner J; Seeringer A
Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
[TBL] [Abstract][Full Text] [Related]
7. [State of the art of pharmacogenetic diagnostics in drug therapy].
Kirchheiner J; Seeringer A; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
[TBL] [Abstract][Full Text] [Related]
8. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.
Cerezo-Manchado JJ; Roldán V; Corral J; Rosafalco M; Antón AI; Padilla J; Vicente V; González-Conejero R
Thromb Haemost; 2016 Jan; 115(1):117-25. PubMed ID: 26538428
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.
Brockmöller J; Kirchheiner J; Meisel C; Roots I
Pharmacogenomics; 2000 May; 1(2):125-51. PubMed ID: 11256586
[TBL] [Abstract][Full Text] [Related]
10. [The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy].
Bairamova SP; Pavlova OV; Shport SV; Gurina OI; Pavlov KA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):40-46. PubMed ID: 37994887
[TBL] [Abstract][Full Text] [Related]
11. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
[TBL] [Abstract][Full Text] [Related]
12. Evidence based drug dosing and pharmacotherapeutic recommendations per genotype.
Deneer VH; van Schaik RH
Methods Mol Biol; 2013; 1015():345-54. PubMed ID: 23824868
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder.
Ramey-Hartung B; El-Mallakh RS; Reynolds KK
Clin Lab Med; 2008 Dec; 28(4):627-43. PubMed ID: 19059067
[TBL] [Abstract][Full Text] [Related]
14. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
15. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.
Eap CB; Jaquenoud Sirot E; Baumann P
Ther Drug Monit; 2004 Apr; 26(2):152-5. PubMed ID: 15228156
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of cardiovascular pharmacogenetics.
Voora D; Ginsburg GS
J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
[TBL] [Abstract][Full Text] [Related]
18. Genotype-guided warfarin therapy: current status.
Tavares LC; Marcatto LR; Santos PCJL
Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
